Anjuli Luthra
Appearances
- DateMay 21, 2024BACKGROUND & AIMS: Differentiating pancreas cyst subtype is a fundamental step to develop management for patients with incidental pancreatic cystic lesions (PCL), but current standard of care has suboptimal accuracy…
Presenter
Speakers
Johns Hopkins MedicineMayo ClinicBaylor College of MedicineParkview HealthBIDMC/Harvard Med SchNYPH Columbia UniversityOhio State University - DateMay 21, 2024Clinical presentation, imaging, and endoscopic ultrasound (EUS) findings, as well as fluid analysis possess prognostic features for intraductal papillary mucinous neoplasms (IPMN); however, classification of IPMN-risk remains challenging1,2…
- DateMay 18, 2024With the increased detection of early gastroesophageal tumors (GET), the role of endoscopic submucosal dissection (ESD) has been expanding as an alternative to surgery…
- DateMay 21, 2024Biliary intraepithelial neoplasm (BilIN) and intraductal papillary neoplasm of the bile duct (IPNB) are two pre-invasive neoplasms that can lead to cholangiocarcinoma (CCA)1. IPNB has a high tendency to present with high-grade dysplasia (HGD), and invasive lesions1…
- DateMay 21, 2024BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Presenter
Speakers
Mayo ClinicUniversity of PittsburghStanford UniversityUniversity of WisconsinIndiana University Health Medical CenterMayo ClinicAdventHealth Orlando
